Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis

被引：9
作者：
Giralt, Sergio [2 ]
Vesole, David H. [3 ]
Somlo, George [5 ]
Krishnan, Amrita [4 ]
Stadtmauer, Edward [6 ]
McCarthy, Philip [7 ]
Pasquini, Marcelo C. [1 ]
机构：
[1] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA
[3] Loyola Univ, Blood & Marrow Transplant Program, Stritch Sch Med, Chicago, IL 60611 USA
[4] City Hope Canc Ctr, Dept Hematol & Hematopoiet Cell Transplant, Los Angeles, CA USA
[5] City Hope Canc Ctr, Dept Med Oncol & Therapeut Res, Los Angeles, CA USA
[6] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[7] Roswell Pk Canc Inst, Bone Marrow Transplant Program, Buffalo, NY 14263 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 13期
关键词：
TRIAL; MAINTENANCE; THALIDOMIDE; MELPHALAN; THERAPY;
D O I：
10.1093/jnci/djp126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：964 / 964
页数：1
相关论文
共 6 条
[1]   RETRACTED: Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma:: results of a multicenter randomized clinical trial (Retracted article. See vol. 113, pg. 6265, 2009) [J].
Abdelkefi, Abderrahman ;
Ladeb, Saloua ;
Torjman, Lamia ;
Ben Othman, Tarek ;
Lakhal, Amel ;
Ben Romdhane, Neila ;
El Omri, Halima ;
Elloumi, Moez ;
Belaaj, Hatem ;
Jeddi, Ramzi ;
Aissaoui, Lamia ;
Ksouri, Habib ;
Ben Hassen, Assia ;
Msadek, Fahmi ;
Saad, Ali ;
Hsaieri, Mohamed ;
Boukef, Kamel ;
Amouri, Ahlem ;
Louzir, Hechmi ;
Dellagi, Koussay ;
Ben Abdeladhim, Abdeladhim .
BLOOD, 2008, 111 (04) :1805-1810
[2]   Clinically relevant end points and new drug approvals for myeloma [J].
Anderson, K. C. ;
Kyle, R. A. ;
Rajkumar, S. V. ;
Stewart, A. K. ;
Weber, D. ;
Richardson, P. .
LEUKEMIA, 2008, 22 (02) :231-239
[3]   Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma [J].
Attal, Michel ;
Harousseau, Jean-Luc ;
Leyvraz, Serge ;
Doyen, Chantal ;
Hulin, Cyrille ;
Benboubker, Lofti ;
Agha, Ibrahim Yakoub ;
Bourhis, Jean-Henri ;
Garderet, Laurent ;
Pegourie, Brigitte ;
Dumontet, Charles ;
Renaud, Marc ;
Voillat, Laurent ;
Berthou, Christian ;
Marit, Gerald ;
Monconduit, Mathieu ;
Caillot, Denis ;
Grobois, Bernard ;
Avet-Loiseau, Herve ;
Moreau, Philippe ;
Facon, Thierry .
BLOOD, 2006, 108 (10) :3289-3294
[4]   Tandem Versus Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis [J].
Kumar, Ambuj ;
Kharfan-Dabaja, Mohamed A. ;
Glasmacher, Axel ;
Djulbegovic, Benjamin .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02) :100-106
[5]   Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma:: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial [J].
Moreau, P ;
Facon, T ;
Attal, M ;
Hulin, C ;
Michallet, M ;
Maloisel, F ;
Sotto, JJ ;
Guilhot, F ;
Marit, G ;
Doyen, C ;
Jaubert, A ;
Fuzibet, JG ;
François, S ;
Benboubker, L ;
Monconduit, M ;
Voillat, L ;
Macro, M ;
Berthou, C ;
Dorvaux, V ;
Pignon, B ;
Rio, B ;
Matthes, T ;
Casassus, P ;
Caillot, D ;
Najman, N ;
Grosbois, B ;
Bataille, R ;
Harousseau, JL .
BLOOD, 2002, 99 (03) :731-735
[6]   Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial [J].
Sonneveld, Pieter ;
van der Holt, Bronno ;
Segeren, Christine M. ;
Vellenga, Edo ;
Croockewit, Alexandra J. ;
Verhoe, Gregor E. G. ;
Cornelissen, Jan J. ;
Schaafsma, Martijn R. ;
van Oers, Marinus H. J. ;
Wijermans, Pierre W. ;
Westveer, Petra H. M. ;
Lokhorst, Henk M. .
HAEMATOLOGICA, 2007, 92 (07) :928-935
1